Lurasidone: Ten Years Treating Adults with Bipolar Depression

Lurasidone: Ten Years Treating Adults with Bipolar Depression

Lurasidone is an atypical antipsychotic approved in 2010 in Canada and in the USA for the treatment of adults with schizophrenia or bipolar type I disorder. In 2014 it was approved in the European Union for the treatment of patients with 13 years‑old or older, with schizophrenia. Lurasidone is a be...

Full description

Bibliographic Details
Main Authors: Margarida Albuquerque, João Facucho-Oliveira, Daniel Esteves-Sousa, Nuno Moura, Daniel Neto, Pedro Cintra
Format: Article
Language:English
Published: Sociedade Portuguesa de Psiquiatria e Saúde Mental 2021-06-01
Series:Revista Portuguesa de Psiquiatria e Saúde Mental
Subjects:
Adult
Antipsychotic Agents/therapeutic use
Bipolar Disorder/drug therapy
Lurasidone Hydrochloride/ therapeutic use
Online Access:https://www.revistapsiquiatria.pt/index.php/sppsm/article/view/199

Internet

https://www.revistapsiquiatria.pt/index.php/sppsm/article/view/199

Similar Items